Aurelio Maggio: The Mission and The Projects We Are Advancing for Rare Hematologic Diseases
Aurelio Maggio, President of Franco and Piera Cutino Foundation, shared on LinkedIn:
”Thalassemia is a rare blood disorder that still affects about 7,000 patients in Italy, many of whom depend on lifelong transfusions.
Research has changed the course of this disease in recent decades, but much remains to be done to prevent complications and move closer to a cure.
At the Franco and Piera Cutino Foundation we work every day on research, prevention and innovative therapies, from early prenatal diagnosis to gene therapy and international collaboration on rare hematologic diseases.
In this video I share the mission and the projects we are advancing, also supported by our Easter solidarity campaign ‘Giving makes you happy’.”
Stay updated with Hemostasis Today.
-
Nov 3, 2026, 16:36Chris Baugh: EMplify Podcast Explores Antithrombotic Associated Bleeding in the Emergency Department
-
Nov 3, 2026, 16:32Carlo Zaninetti: Highlights from the XXIX Congress of the Italian Society on Haemostasis and Thrombosis
-
Nov 3, 2026, 15:10Lady Joan Branson’s Story – The Hidden Danger of Hospitalization
-
Nov 3, 2026, 14:38Emna Hammami: Exploring the Haemophilia Treatment Landscape at the EHC New Technologies Conference
-
Nov 3, 2026, 14:20EHC Marks the Final Edition of Its New Technologies Conference in Bucharest
-
Nov 3, 2026, 14:15Rhiannon Morris: Awarded CASS Foundation Travel Grant to Present Research at ASH 2026
-
Nov 3, 2026, 14:14Edward Barnard: New Study Identifies an Association Between O Negative Blood Group and Trauma Mortality
-
Nov 3, 2026, 14:05Paula Escarcena Fernández: Selective Genicular Artery Embolization for Complex Regional Pain Syndrome of the Knee
-
Nov 3, 2026, 13:55Heiko Tschauner: New NOM-253 Standard Sets Higher Requirements for Blood Services in Mexico